Published • loading... • Updated
AEON Reports New Data on Botox Biosimilar - Orange County Business Journal
Summary by ocbj.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
AEON Reports New Data on Botox Biosimilar - Orange County Business Journal
Aeon Biopharma Inc. today announced data supporting the molecular similarity of its ABP-450 treatment to Botox. It expects to meet with the FDA for a Biosimilar Biological Product Development (BPD) Type 2b meeting before the end of the year. The biopharmaceutical company moved its headquarters from Irvine to Aliso Viejo some time in June, according to recent regulatory filings. Shares in the company were down 5% to 23 cents per share and an $11.…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
